Difficulty: Medium
Average Score: 63%
Practice
The antenatal administration of magnesium sulfate before preterm delivery has been suggested to
Correct answer
B
Rationale
The correct answer is B) Decrease the risk of cerebral palsy in surviving infants. Administering magnesium sulfate antenatally before preterm delivery has been shown to reduce the risk of cerebral palsy in surviving infants. This is because magnesium sulfate has neuroprotective properties that help in reducing brain injury and neurological deficits in preterm infants.
Option A) Reduce rates of necrotizing enterocolitis is incorrect as magnesium sulfate administration is not primarily aimed at reducing necrotizing enterocolitis in preterm infants. Option C) Improve overall survival is not directly related to the administration of magnesium sulfate, as its main benefit lies in reducing the risk of cerebral palsy rather than overall survival. Option D) Decrease respiratory distress syndrome in premature infants is also incorrect, as magnesium sulfate does not have a significant impact on respiratory distress syndrome.
In an educational context, it is crucial for pediatric nurses to understand the benefits and implications of antenatal magnesium sulfate administration in preterm deliveries. This knowledge is essential for providing evidence-based care to pregnant women at risk of preterm labor and in improving outcomes for preterm infants, particularly in reducing the risk of cerebral palsy. Understanding the rationale behind using magnesium sulfate can guide nursing practice and contribute to better patient outcomes in neonatal care.
Option A) Reduce rates of necrotizing enterocolitis is incorrect as magnesium sulfate administration is not primarily aimed at reducing necrotizing enterocolitis in preterm infants. Option C) Improve overall survival is not directly related to the administration of magnesium sulfate, as its main benefit lies in reducing the risk of cerebral palsy rather than overall survival. Option D) Decrease respiratory distress syndrome in premature infants is also incorrect, as magnesium sulfate does not have a significant impact on respiratory distress syndrome.
In an educational context, it is crucial for pediatric nurses to understand the benefits and implications of antenatal magnesium sulfate administration in preterm deliveries. This knowledge is essential for providing evidence-based care to pregnant women at risk of preterm labor and in improving outcomes for preterm infants, particularly in reducing the risk of cerebral palsy. Understanding the rationale behind using magnesium sulfate can guide nursing practice and contribute to better patient outcomes in neonatal care.